Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
5.07
-0.06 (-1.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
Evoke Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 10 | 4 | 9 | 18 | 68 | 39 | |
| Market Cap Growth | 53.15% | -60.81% | -50.12% | -73.62% | 73.44% | -9.17% | |
| Enterprise Value | 4 | 3 | 2 | 12 | 64 | 33 | |
| Last Close Price | 5.07 | 12.60 | 32.16 | 79.20 | 371.52 | 233.28 | |
| PS Ratio | 0.87 | 0.68 | 3.57 | 11.10 | 2957.72 | - | |
| PB Ratio | 1.71 | -1.36 | 2.19 | 5.05 | -21.18 | 8.96 | |
| P/TBV Ratio | 1.61 | - | 2.19 | 5.05 | - | 8.96 | |
| EV/Sales Ratio | 0.48 | 0.49 | 0.70 | 7.33 | 2777.86 | - | |
| Debt / Equity Ratio | 1.14 | -1.94 | 1.26 | 1.41 | -1.63 | 0.03 | |
| Asset Turnover | 0.78 | 0.55 | 0.22 | 0.16 | 0.00 | - | |
| Inventory Turnover | 0.60 | 0.52 | 1.56 | 1.56 | - | - | |
| Quick Ratio | 1.37 | 0.56 | 6.33 | 6.72 | 1.07 | 2.81 | |
| Current Ratio | 1.44 | 0.71 | 7.08 | 7.51 | 1.23 | 3.10 | |
| Return on Equity (ROE) | -349.91% | -1035.44% | -215.30% | -5015.39% | -2256.53% | -169.54% | |
| Return on Assets (ROA) | -33.50% | -49.09% | -43.40% | -50.93% | -103.03% | -74.18% | |
| Return on Capital (ROIC) | -54.51% | -79.84% | -54.74% | -96.14% | -248.98% | -104.67% | |
| Earnings Yield | -58.67% | -221.93% | -91.79% | -47.54% | -19.32% | -18.15% | |
| FCF Yield | -50.82% | -141.97% | -73.62% | -68.78% | -9.74% | -14.68% | |
| Buyback Yield / Dilution | -429.66% | -6.34% | -17.21% | -26.26% | -14.33% | -34.29% | |
| Total Shareholder Return | -429.66% | -6.34% | -17.21% | -26.26% | -14.33% | -34.29% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.